Canada markets close in 5 hours 16 minutes

DNA Jan 2025 5.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.03000.0000 (0.00%)
As of 09:39AM EDT. Market open.
Full screen
Previous Close0.0300
Open0.0300
Bid0.0000
Ask0.1000
Strike5.50
Expire Date2025-01-17
Day's Range0.0300 - 0.0300
Contract RangeN/A
Volume1
Open Interest7.43k
  • PR Newswire

    Ginkgo Bioworks to Participate in Two Conferences in May

    Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that management will be participating in two investor conferences in May.

  • PR Newswire

    Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan

    Sojitz, a large Japanese general trading company with extensive networks within the Japanese bioeconomy, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that they have entered into a binding definitive agreement. Together, Sojitz and Ginkgo aim to build connections with key Japanese businesses and encourage the use of synthetic biology to develop sustainable production processes.

  • PR Newswire

    Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE

    Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biosecurity, today announced that it received a notice on May 7, 2024 from the New York Stock Exchange ("NYSE") informing the Company that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's Class A common stock was less than $1 per share over a consecutive 30 trading-day period. The no